Historical data in the design and interpretation of trials with newly diagnosed patients
- 27 December 2005
- journal article
- review article
- Published by Elsevier in Epilepsy Research
- Vol. 68 (1) , 77-81
- https://doi.org/10.1016/j.eplepsyres.2005.09.028
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Randomized dose-controlled study of topiramate as first-line therapy in epilepsyActa Neurologica Scandinavica, 2005
- Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trialThe Lancet, 2005
- Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomesStatistics in Medicine, 2005
- The use of putative placebo in active control trials: two applications in a regulatory settingStatistics in Medicine, 2003
- A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsyNeurology, 2003
- Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential AnalysisEpilepsy & Behavior, 2002
- Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizuresNeurology, 2001
- Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placeboAmerican Heart Journal, 2001
- Monotherapy Trials with Gabapentin for Partial EpilepsyEpilepsia, 1999
- A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizuresNeurology, 1998